About Akouos
Akouos is a company based in Boston (United States) founded in 2016 was acquired by Lilly in October 2022.. Akouos has raised $162.65 million across 4 funding rounds from investors including Fidelity Investments, Lilly and TD Securities. The company has 92 employees as of December 31, 2022. Akouos offers products and services including Gene Therapies. Akouos operates in a competitive market with competitors including BridgeBio, Spark Therapeutics, Alnylam, ATAI and Insitro, among others.
- Headquarter Boston, United States
- Employees 92 as on 31 Dec, 2022
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Akouos, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$162.65 M (USD)
in 4 rounds
-
Latest Funding Round
$105.07 M (USD), Series B
Mar 03, 2020
-
Investors
Fidelity Investments
& 15 more
-
Employee Count
92
as on Dec 31, 2022
-
Acquired by
Lilly
(Oct 18, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Akouos
Akouos offers a comprehensive portfolio of products and services, including Gene Therapies. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Develop treatments to restore hearing through genetic interventions
Unlock access to complete
Unlock access to complete
Funding Insights of Akouos
Akouos has successfully raised a total of $162.65M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $105.07 million completed in March 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series B — $105.1M
-
First Round
First Round
(04 Apr 2017)
- Investors Count 15
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2020 | Amount | Series B - Akouos | Valuation | Pivotal bioVenture Partners | |
| Aug, 2018 | Amount | Series A - Akouos | Valuation | 5AM Ventures , New Enterprise Associates | |
| Nov, 2017 | Amount | Seed - Akouos | Valuation | 5AM Ventures , New Enterprise Associates |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Akouos
Akouos has secured backing from 16 investors, including institutional and venture fund investors. Prominent investors backing the company include Fidelity Investments, Lilly and TD Securities. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
US focused venture capital firm
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Akouos
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Akouos
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Akouos Comparisons
Competitors of Akouos
Akouos operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BridgeBio, Spark Therapeutics, Alnylam, ATAI and Insitro, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| domain | founded_year | HQ Location |
RNA interference-based therapeutics are developed for multiple disorders.
|
|
| domain | founded_year | HQ Location |
A biopharmaceutical company accelerating innovative mental health treatments.
|
|
| domain | founded_year | HQ Location |
An AI-enabled platform is developed for infectious disease treatment.
|
|
| domain | founded_year | HQ Location |
Cell-based therapies for cancer treatment are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Akouos
Frequently Asked Questions about Akouos
When was Akouos founded?
Akouos was founded in 2016 and raised its 1st funding round 1 year after it was founded.
Where is Akouos located?
Akouos is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Is Akouos a funded company?
Akouos is a funded company, having raised a total of $162.65M across 4 funding rounds to date. The company's 1st funding round was a Seed of $7.58M, raised on Apr 04, 2017.
How many employees does Akouos have?
As of Dec 31, 2022, the latest employee count at Akouos is 92.
What does Akouos do?
Akouos was founded in 2016 in Boston, United States, within the biotechnology sector focused on auditory health. Gene therapies and delivery systems are developed to address hearing loss and balance disorders in specific genetic patient groups. Strategic licensing agreements have been established with Lonza and Massachusetts Eye and Ear for the Anc-AAV vector platform. Initial incubation occurred at Harvard Life Lab to support early operations.
Who are the top competitors of Akouos?
Akouos's top competitors include Spark Therapeutics, BridgeBio and Forge Biologics.
What products or services does Akouos offer?
Akouos offers Gene Therapies.
Who are Akouos's investors?
Akouos has 16 investors. Key investors include Fidelity Investments, Lilly, TD Securities, Citadel, and HHS.